CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-12 | KEATING LAURIE EVP, Chief Legal Officer | Sale | −1,812 | $179.00 | $324K | 10,132 |
| 2021-07-12 | KEATING LAURIE EVP, Chief Legal Officer | Sale | −5,000 | $178.95 | $895K | 5,132 |
| 2021-07-12 | KEATING LAURIE EVP, Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) | −1,812 | 17,188 | ||
| 2021-07-12 | KEATING LAURIE EVP, Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) | −5,000 | 9,000 | ||
| 2021-06-18 | Vaishnaw Akshay President, R&D | Exercise or conversion | +10,834 | $63.00 | $683K | 24,953 |
| 2021-06-18 | Vaishnaw Akshay President, R&D | Exercise or conversion | +970 | $42.22 | $41K | 25,923 |
| 2021-06-18 | Vaishnaw Akshay President, R&D | Sale | −14,708 | $175.00 | $2.6M | 11,215 |
| 2021-06-18 | Vaishnaw Akshay President, R&D | Exercise or conversion · Performance Stock Option 2013 (right to buy) | −10,834 | 21,666 | ||
| 2021-06-18 | Vaishnaw Akshay President, R&D | Exercise or conversion · Stock Option (right to buy) | −970 | 2,368 | ||
| 2021-06-09 | KEATING LAURIE EVP, Chief Legal Officer | Sale | −1,734 | $154.00 | $267K | 5,132 |
| 2021-05-13 | MARAGANORE JOHN Chief Executive Officer | Exercise or conversion | +33,979 | $7.10 | $241K | 248,744 |
| 2021-05-13 | MARAGANORE JOHN Chief Executive Officer | Sale | −3,015 | $128.30 | $387K | 245,729 |
| 2021-05-13 | MARAGANORE JOHN Chief Executive Officer | Sale | −4,512 | $129.32 | $583K | 241,217 |
| 2021-05-13 | MARAGANORE JOHN Chief Executive Officer | Sale | −9,121 | $130.34 | $1.2M | 232,096 |
| 2021-05-13 | MARAGANORE JOHN Chief Executive Officer | Sale | −11,203 | $131.18 | $1.5M | 220,893 |
| 2021-05-13 | MARAGANORE JOHN Chief Executive Officer | Sale | −3,481 | $132.32 | $461K | 217,412 |
| 2021-05-13 | MARAGANORE JOHN Chief Executive Officer | Sale | −1,624 | $133.56 | $217K | 215,788 |
| 2021-05-13 | MARAGANORE JOHN Chief Executive Officer | Sale | −1,023 | $134.37 | $137K | 214,765 |
| 2021-05-13 | MARAGANORE JOHN Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −33,979 | 67,957 | ||
| 2021-04-21 | Vaishnaw Akshay President, R&D | Sale | −203 | $135.41 | $27K | 16,648 |
Page 68 of 80 · 1,590 trades